CONTACT INFORMATIONCREDENTIALSAWARDSPATENTSPUBLICATIONSMargot Mayer-Proschel, Ph.D.Contact InformationPhone NumbersAppointment: (585) 273-1449Administrative: (585) 273-1440Office: (585) 273-1449Fax: (585) 273-1450Research LabsVisit Lab WebsiteLocationsUniversity of Rochester Medical CenterSchool of Medicine and Dentistry601 Elmwood Ave, Box 633Rochester, NY 14642Faculty AppointmentsProfessor - Department of Biomedical Genetics (SMD) Professor - Department of Neuroscience (SMD) - JointBiographyResearch1. Identification of lineage restricted precursor cells for cell replacement The concept of progressive lineage restriction is well accepted for hematopoeisis but has not been established in such detail in the developing CNS. We are pursuing how lineage restriction is regulated in various brain regions of the CNS and have discovered that embryonic glial precursor cells do not directly generate terminally differentiated cell types, but give rise to other, more restricted precursor cell types before terminal differentiation. The identification of these different cell pools is critical for identifying ideal transplantable cells for therapeutic cell replacement approaches. The therapeutic translation of our knowledge of precursor cells and their derivatives is demonstrated in our collaborative efforts on designing optimal repair strategies for spinal cord injuries. With our colleagues Drs. Chris Proschel, Mark Noble and Stephen and Jeanette Davies at the University of Colorado we showed that the transplantation of a defined embryonic astrocyte population into a dorsal transection models of SCI results in extensive regeneration associated with complete functional recovery. We are now in the process of extending these finding by devising a rational approach to identify the optimal cell source and cell population for SCI repair and by characterizing the graft cells and the injury site in respect to cell death, inflammation and cell division. 2. CNS precursor cells and their derivatives in human disease paradigms The insights we have gained from studying CNS glial precursor cells has led to the idea that precursor cell populations are targets for a large number of developmental abnormalities associated with myelination defects in humans. Defects in myelination are associated with insults as diverse as genetic defects, exposure to toxicant or to nutritional deficiencies. Based on our precursor cell work, we hypothesize that adequate myelination of large areas of the mammalian brain will only be possible if precursor cells arise in adequate numbers and continue to develop normally throughout development. Any disruption of the precursor cell pool might hence be associated with myelination defects later in development. Gestational Iron deficiency. Our hypothesis of precursor cells being a major target during development is especially relevant for the pathology seen as a result of gestational nutritional iron deficiency. This world's most prevalent nutritional deficiency is associated with impaired myelination and results in cognitive defects in affected children. We have shown that embryonic CNS tissue is not protected from iron deficiency during pregnancy, as commonly thought, and that early glial precursor cell populations are highly sensitive to changes in tissue iron concentrations. We have established rat and mouse models of gestation iron deficiency with and without anemia to determine the impact of gestational iron deficiency on brain development with a focus on (i) early embryonic telencephalic development and (ii) myelination of the auditory nerve postnatally. Ataxia Telangiectasia (AT) A genetic disorder associated with widespread neurological defects is the devastating disease Ataxia telangiectasia (AT), caused by mutations in the ATM gene. The pathology is characterized by crippling ataxia beginning in late infancy followed by progressive CNS degeneration of the cerebellum. While the majority of research has been focused on the neuronal cell population affected in the cerebellum, we began to determine the extent of glial dysfunction on the progression of AT. Our result indicate that astrocytic function is severely impaired in AT CNS tissue and we show that AT mutant astrocytes are unable to maintain neuronal integrity and survival. This new discovery opens the possibility for generating new therapeutic strategies that target the dysfunction astrocytes in order to halt or abolish neuronal degeneration.CredentialsEducation1986MS | Julius Maximilian UniversityImmunology1990PhD | Inst. Of Virology & Immunology, Univ of WurzburgVirology/MicrobiologyPost-doctoral Training & Residency1990 - 1995Dept of Developmental Biology, Ludwig Institute for Cancer Research, London, UK (Mentor: Mark Noble)Awards2007Graduate Student Society Faculty AwardSponsor: University of Rochester2006Excellence in Research incentive program AwardSponsor: University of Rochester2004Excellence in Research incentive program AwardSponsor: University of Rochester2004Trainee Academic Mentoring AwardSponsor: University of RochesterVIEW ALL expand_morePatentsPatent Title: Transplantation of Glial Restricted Precursor - Derived Astrocytes For Promotion of Axon Growth Patent #: ZL200680040380.5 Issue Date: Jun 12, 2013 Country: China, People's Republic of Invented By: Jeannette Davies, Stephen Davies, Margot Mayer-Proschel, Mark D Noble, Christoph ProschelPatent Title: Telencephalic Glial-Restricted Cell Populations and Related Compositions and Methods Patent #: ZL200880012443.5 Issue Date: Sep 11, 2013 Country: China, People's Republic of Invented By: Margot Mayer-Proschel, Frederick StrathmannPublicationsJournal Articles8/30/2022Hogestyn JM, Salois G, Xie L, Apa C, Youngyunpipatkul J, Pröschel C, Mayer-Pröschel M. "Expression of the human herpesvirus 6A latency-associated transcript U94A impairs cytoskeletal functions in human neural cells." Molecular and cellular neurosciences.. 2022 Aug 30; :103770. Epub 2022 Aug 30. 2/23/2022Warren R, Dylag AM, Behan M, Domm W, Yee M, Mayer-Proschel M, Martinez L, O'Reilly MA. "Ataxia telangiectasia mutated is required for efficient proximal airway epithelial cell regeneration following influenza A virus infection." American journal of physiology. Lung cellular and molecular physiology.. 2022 Feb 23; Epub 2022 Feb 23. 9/11/2019Warren R, Domm W, Yee M, Campbell A, Malone J, Wright T, Mayer-Proschel M, O'Reilly MA. "Ataxia-telangiectasia mutated is required for the development of protective immune memory after influenza A virus infection." American journal of physiology. Lung cellular and molecular physiology.. 2019 Sep 11; Epub 2019 Sep 11. Books & Chapters2001 Chapter Title: PreGlial restricted Precursors Book Title: Stem cells and CNS development Author List: Noble M., Mayer-Proschel M. Published By: Rao M. Humana Press Inc 20011998 Book Title: Isolation and purification of oligodendrocytes Author List: Mayer-Proschel M. Edited By: Ron McKay Published By: John Wiley and Sons 1998VIEW ALL PUBLICATIONSClose WindowSchedule an appointment with Margot Mayer-Proschel, Ph.D.Please answer the following questions to help us find the right appointment for you.Important: If you believe that you have a medical or psychiatric emergency, please call 911 or go to the nearest hospital. This website is not intended for emergency care.Have you seen this provider in the last 2 years?YesNoExisting Patient Schedule or request a follow up appointment online through MyChart. If you do not have a MyChart account, please close this window and call the appointment phone number. Margot Mayer-Proschel, Ph.D. is currently scheduling for the following appointment type(s): Our policy does not permit patients to establish care with multiple providers within the same practice or specialty without prior approval. If you choose a new provider in the same office, we will cancel the appointment. Please contact the office directly with questions on this policy.